Oxford Vacmedix and CHAIN Biotech collaborate to develop oral vaccines
Oxford Vacmedix and CHAIN Biotech have signed Heads of Terms for a Collaboration Agreement to develop and commercialise oral vaccines targeting cancer & infectious disease Oxford, UK – 4th January 2020 – FOR IMMEDIATE RELEASE Press Release – OVM CHAIN Collaboration Oxford 4th Jan 2020; Oxford Vacmedix (OVM), the UK based biopharma company, focused on …
Oxford Vacmedix and CHAIN Biotech collaborate to develop oral vaccines Read More »